Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Michael Tuttle

Showing results (21-30 of 320) with videos related to

Pageof 32
Sort By:
Oncology (Williston Park, N.Y.)|July 25, 2009
Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients?R Michael Tuttle, James A Fagin
Indian Journal of Cancer|June 8, 2021
Papillary microcarcinoma-Management issuesAshok R Shaha, R Michael Tuttle
Surgery|November 30, 2020
Commentary: Re-recurrence after surgical management of recurrent thyroid cancerAshok R Shaha, R Michael Tuttle
Journal of Surgical Oncology|March 13, 2021
Delphian node-A sentinel node in thyroid cancer?Ashok R Shaha, R Michael Tuttle
Annals of Translational Medicine|April 30, 2019
Thyroid cancer staging and genomicsAshok R Shaha, R Michael Tuttle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Recombinant human thyroid-stimulating hormone to stimulate 131-I uptake for remnant ablation and adjuvant therapyMona M Sabra, R Michael Tuttle
Surgery|March 25, 2019
Commentary "Incidence of total thyroidectomy and lobectomy"Ashok R Shaha, R Michael Tuttle
Endocrinology and Metabolism Clinics of North America|June 4, 2014
Update on differentiated thyroid cancer stagingDenise P Momesso, R Michael Tuttle
The Journal of Clinical Endocrinology and Metabolism|March 16, 2019
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-UpR Michael Tuttle, Ali S Alzahrani
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 3, 2019
Completion thyroidectomy-indications and complicationsAshok R Shaha, R Michael Tuttle
Pageof 32

Showing results (21-30 of 320) with videos related to

Sort By:
Pageof 32
Oncology (Williston Park, N.Y.)|July 25, 2009
Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients?R Michael Tuttle, James A Fagin
Indian Journal of Cancer|June 8, 2021
Papillary microcarcinoma-Management issuesAshok R Shaha, R Michael Tuttle
Surgery|November 30, 2020
Commentary: Re-recurrence after surgical management of recurrent thyroid cancerAshok R Shaha, R Michael Tuttle
Journal of Surgical Oncology|March 13, 2021
Delphian node-A sentinel node in thyroid cancer?Ashok R Shaha, R Michael Tuttle
Annals of Translational Medicine|April 30, 2019
Thyroid cancer staging and genomicsAshok R Shaha, R Michael Tuttle
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|November 29, 2012
Recombinant human thyroid-stimulating hormone to stimulate 131-I uptake for remnant ablation and adjuvant therapyMona M Sabra, R Michael Tuttle
Surgery|March 25, 2019
Commentary "Incidence of total thyroidectomy and lobectomy"Ashok R Shaha, R Michael Tuttle
Endocrinology and Metabolism Clinics of North America|June 4, 2014
Update on differentiated thyroid cancer stagingDenise P Momesso, R Michael Tuttle
The Journal of Clinical Endocrinology and Metabolism|March 16, 2019
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-UpR Michael Tuttle, Ali S Alzahrani
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 3, 2019
Completion thyroidectomy-indications and complicationsAshok R Shaha, R Michael Tuttle
Pageof 32